monitoring of circulating tumor plasma cells in pts with precursor conditions of mm: istopmm
Published 2 years ago • 184 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
5:54
circulating tumor plasma cells in the screened istopmm smoldering multiple myeloma cohort
-
50:47
monitoring circulating plasma cells in routine diagnostics in multiple myeloma
-
49:36
multiple myeloma precursor conditions | overview | therapeutic intervention
-
6:40
determining hemodilution in diagnostic bone marrow samples in mm and its precursors by ngf cytometry
-
3:00
current & emerging biomarkers in multiple myeloma
-
2:49
circulating tumor cell burden as a component of staging in multiple myeloma
-
2:00
rna profiling of circulating tumor cells in myeloma patients
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
4:37
multiple myeloma precursor conditions | high impact topic (hit)
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
1:33
circulating tumor cells in multiple myeloma
-
32:02
faqs on multiple myeloma precursor conditions.
-
1:02:03
understanding blood-based testing in multiple myeloma with ola landgren, md, phd
-
3:55
what is the imf's istopmm study? early screening for myeloma: advantages, impact, and benefits
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
3:38
non-invasive monitoring of smoldering multiple myeloma
-
6:54
prevalence of smoldering multiple myeloma: results from the istopmm study
-
48:12
circulating tumor cells for the staging of patients with newly diagnosed transplant-eligible mm
-
8:07
mgus with multiple paraproteins: results from the population-based istopmm screening study